Aarhus Universitets segl

English

Du er her: AU » Om AU » Organisation » Circulating tumor DNA for prognosis assessment and postop...

Om AU

Circulating tumor DNA for prognosis assessment and postoperative management after curative-intent resection of colorectal liver metastases

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review

Links

DOI

The recurrence rate of colorectal liver metastases (CRLM) patients treated with curative intent is above 50%. Standard of care surveillance includes intensive computed tomographic (CT) imaging as well as carcinoembryonic antigen (CEA) measurements. Nonetheless, relapse detection often happens too late to resume curative treatment. This longitudinal cohort study enrolled 115 patients with plasma samples (N = 439) prospectively collected before surgery, postoperatively at day 30 and every third month for up to 3 years. Droplet digital PCR (ddPCR) was used to monitor serial plasma samples for somatic mutations. Assessment of ctDNA status either immediately after surgery, or serially during surveillance, stratified the patients into groups of high and low recurrence risk (hazard ratio [HR], 7.6; 95% CI, 3.0-19.7; P <.0001; and HR, 4.3; 95% CI, 2.3-8.1; P <.0001, respectively). The positive predictive value (PPV) of ctDNA was 100% in all postoperative analyses. In multivariable analyses, postoperative ctDNA status was the only consistently significant risk marker associated with relapse (P <.0001). Indeterminate CT findings were observed for 30.8% (21/68) of patients. All patients (9/21) that were ctDNA positive at the time of the indeterminate CT scan later relapsed, contrasting 42.6% (5/12) of those ctDNA negative (P =.0046). Recurrence diagnoses in patients with indeterminate CT findings were delayed (median 2.8 months, P <.0001). ctDNA status is strongly associated with detection of minimal residual disease and early detection of relapse. Furthermore, ctDNA status can potentially contribute to clinical decision-making in case of indeterminate CT findings, reducing time-to-intervention.

OriginalsprogEngelsk
TidsskriftInternational Journal of Cancer
Vol/bind150
Nummer9
Sider (fra-til)1537-1548
Antal sider12
ISSN0020-7136
DOI
StatusUdgivet - maj 2022

    Forskningsområder

  • Colorectal cancer liver metastases, Circulating tumor DNA, Minimal residual disease, Recurrence surveillance, Droplet digital PCR

Se relationer på Aarhus Universitet Citationsformater

ID: 229436023